Literature DB >> 15932233

A Re(V)-catalyzed C-N bond-forming route to human lipoxygenase inhibitors.

Rachana V Ohri1, Alexander T Radosevich, K James Hrovat, Christine Musich, David Huang, Theodore R Holman, F Dean Toste.   

Abstract

[reaction: see text] A regioselective synthesis of propargylamines by the coupling of propargyl alcohols with tosylamines and carbamates catalyzed by an air- and moisture-tolerant rhenium-oxo complex is described. The ability to couple functionalized components allows for convergent approaches to nitrogen-containing heterocyclic compounds such as the marine antibiotic pentabromopseudilin. These compounds were assayed against human lipoxygenase and found to be both potent and selective.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932233     DOI: 10.1021/ol050897a

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  11 in total

1.  Highly brominated antimicrobial metabolites from a marine Pseudoalteromonas sp.

Authors:  Domonkos Fehér; Russell Barlow; Jesse McAtee; Thomas K Hemscheidt
Journal:  J Nat Prod       Date:  2010-10-25       Impact factor: 4.050

2.  Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase.

Authors:  Diane K Luci; J Brian Jameson; Adam Yasgar; Giovanni Diaz; Netra Joshi; Auric Kantz; Kate Markham; Steve Perry; Norine Kuhn; Jennifer Yeung; Edward H Kerns; Lena Schultz; Michael Holinstat; Jerry L Nadler; David A Taylor-Fishwick; Ajit Jadhav; Anton Simeonov; Theodore R Holman; David J Maloney
Journal:  J Med Chem       Date:  2014-01-06       Impact factor: 7.446

3.  Enantioselective reduction of ketones and imines catalyzed by (CN-box)Re(V)-oxo complexes.

Authors:  Kristine A Nolin; Richard W Ahn; Yusuke Kobayashi; Joshua J Kennedy-Smith; F Dean Toste
Journal:  Chemistry       Date:  2010-08-16       Impact factor: 5.236

4.  Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.

Authors:  Victor Kenyon; Ganesha Rai; Ajit Jadhav; Lena Schultz; Michelle Armstrong; J Brian Jameson; Steven Perry; Netra Joshi; James M Bougie; William Leister; David A Taylor-Fishwick; Jerry L Nadler; Michael Holinstat; Anton Simeonov; David J Maloney; Theodore R Holman
Journal:  J Med Chem       Date:  2011-07-08       Impact factor: 7.446

5.  Discovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1.

Authors:  Ganesha Rai; Victor Kenyon; Ajit Jadhav; Lena Schultz; Michelle Armstrong; J Brian Jameson; Eric Hoobler; William Leister; Anton Simeonov; Theodore R Holman; David J Maloney
Journal:  J Med Chem       Date:  2010-10-28       Impact factor: 7.446

6.  Enzymatic Studies of Isoflavonoids as Selective and Potent Inhibitors of Human Leukocyte 5-Lipo-Oxygenase.

Authors:  Carolina Mascayano; Victoria Espinosa; Silvia Sepúlveda-Boza; Eric K Hoobler; Steve Perry; Giovanni Diaz; Theodore R Holman
Journal:  Chem Biol Drug Des       Date:  2014-11-28       Impact factor: 2.817

Review 7.  Scope and advances in the catalytic propargylic substitution reaction.

Authors:  Rashmi Roy; Satyajit Saha
Journal:  RSC Adv       Date:  2018-09-05       Impact factor: 3.361

8.  The mechanism of pentabromopseudilin inhibition of myosin motor activity.

Authors:  Roman Fedorov; Markus Böhl; Georgios Tsiavaliaris; Falk K Hartmann; Manuel H Taft; Petra Baruch; Bernhard Brenner; René Martin; Hans-Joachim Knölker; Herwig O Gutzeit; Dietmar J Manstein
Journal:  Nat Struct Mol Biol       Date:  2009-01-04       Impact factor: 15.369

9.  Gold-catalyzed propargylic substitutions: Scope and synthetic developments.

Authors:  Olivier Debleds; Eric Gayon; Emmanuel Vrancken; Jean-Marc Campagne
Journal:  Beilstein J Org Chem       Date:  2011-06-28       Impact factor: 2.883

10.  Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies.

Authors:  Ganesha Rai; Netra Joshi; Joo Eun Jung; Yu Liu; Lena Schultz; Adam Yasgar; Steve Perry; Giovanni Diaz; Qiangli Zhang; Victor Kenyon; Ajit Jadhav; Anton Simeonov; Eng H Lo; Klaus van Leyen; David J Maloney; Theodore R Holman
Journal:  J Med Chem       Date:  2014-05-13       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.